Residual tumor volume and survival after CCNU/TMZ in GBM
Neuro-Oncology: The Podcast - Ein Podcast von Neuro-Oncology
Dr. Iyad Alnahhas interviews Drs. Thomas Zeyen and Johannes Weller about their recent manuscript entitled: "Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with CCNU/TMZ", published online in Neuro-Oncology in October 2024.
